Cargando…
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
Cardiovascular diseases (CVDs) have been on the rise around the globe in the past few decades despite the existing guidelines for prevention and treatment. Short-chain fatty acids (SCFAs) are the main metabolites of certain colonic anaerobic bacterial fermentation in the gastrointestinal tract and h...
Autores principales: | Lu, Yingdong, Zhang, Yang, Zhao, Xin, Shang, Chang, Xiang, Mi, Li, Li, Cui, Xiangning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403138/ https://www.ncbi.nlm.nih.gov/pubmed/36035928 http://dx.doi.org/10.3389/fcvm.2022.900381 |
Ejemplares similares
-
Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma
por: Palm, Constantin L., et al.
Publicado: (2022) -
Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats
por: Xiang, Mi, et al.
Publicado: (2023) -
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health
por: Chambers, Edward S., et al.
Publicado: (2018) -
Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2015) -
The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
por: Qin, Li, et al.
Publicado: (2023)